Spectrix Therapeutics, LLC — Form D
Spectrix Therapeutics, LLC of SOUTHLAKE, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-03. The offering totals $249K, of which $249K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-06-03
- Form: D
- Accession: 0001675383-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $249K
- Amount sold: $249K
- Investors: 5
- Date of first sale: 2016-05-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-264350
Issuer
- Name: Spectrix Therapeutics, LLC
- CIK: 0001675383
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2535 EAST SOUTHLAKE BOULEVARD, SOUTHLAKE, TX, 76092
- Phone: 817-313-9539
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Mark Tengler | Executive Officer | Grand Prairie, TX |
More